371 related articles for article (PubMed ID: 28673568)
1. Metformin exerts anti-obesity effect via gut microbiome modulation in prediabetics: A hypothesis.
Maniar K; Moideen A; Bhattacharyya R; Banerjee D
Med Hypotheses; 2017 Jul; 104():117-120. PubMed ID: 28673568
[TBL] [Abstract][Full Text] [Related]
2. Modulation of gut microbiota by berberine and metformin during the treatment of high-fat diet-induced obesity in rats.
Zhang X; Zhao Y; Xu J; Xue Z; Zhang M; Pang X; Zhang X; Zhao L
Sci Rep; 2015 Sep; 5():14405. PubMed ID: 26396057
[TBL] [Abstract][Full Text] [Related]
3. Targeting the Intestinal Microbiota to Prevent Type 2 Diabetes and Enhance the Effect of Metformin on Glycaemia: A Randomised Controlled Pilot Study.
Palacios T; Vitetta L; Coulson S; Madigan CD; Lam YY; Manuel R; Briskey D; Hendy C; Kim JN; Ishoey T; Soto-Giron MJ; Schott EM; Toledo G; Caterson ID
Nutrients; 2020 Jul; 12(7):. PubMed ID: 32660025
[TBL] [Abstract][Full Text] [Related]
4. Disentangling type 2 diabetes and metformin treatment signatures in the human gut microbiota.
Forslund K; Hildebrand F; Nielsen T; Falony G; Le Chatelier E; Sunagawa S; Prifti E; Vieira-Silva S; Gudmundsdottir V; Pedersen HK; Arumugam M; Kristiansen K; Voigt AY; Vestergaard H; Hercog R; Costea PI; Kultima JR; Li J; Jørgensen T; Levenez F; Dore J; ; Nielsen HB; Brunak S; Raes J; Hansen T; Wang J; Ehrlich SD; Bork P; Pedersen O
Nature; 2015 Dec; 528(7581):262-266. PubMed ID: 26633628
[TBL] [Abstract][Full Text] [Related]
5. A story of metformin-butyrate synergism to control various pathological conditions as a consequence of gut microbiome modification: Genesis of a wonder drug?
Maniar K; Moideen A; Mittal A; Patil A; Chakrabarti A; Banerjee D
Pharmacol Res; 2017 Mar; 117():103-128. PubMed ID: 27939359
[TBL] [Abstract][Full Text] [Related]
6. Effect of metformin and metformin/linagliptin on gut microbiota in patients with prediabetes.
Estrella MY; Daniel NR; Armando ED; Cristian PM; Aarón VJ; Paul SJ; David GV; Cristian MO; de Lourdes RM; Lola EM; Alberto AG; Osbaldo RA; Rodolfo GM
Sci Rep; 2024 Apr; 14(1):9678. PubMed ID: 38678119
[TBL] [Abstract][Full Text] [Related]
7. Metformin: Mechanisms in Human Obesity and Weight Loss.
Yerevanian A; Soukas AA
Curr Obes Rep; 2019 Jun; 8(2):156-164. PubMed ID: 30874963
[TBL] [Abstract][Full Text] [Related]
8. The role of gut microbiota in obesity, diabetes mellitus, and effect of metformin: new insights into old diseases.
Pascale A; Marchesi N; Govoni S; Coppola A; Gazzaruso C
Curr Opin Pharmacol; 2019 Dec; 49():1-5. PubMed ID: 31015106
[TBL] [Abstract][Full Text] [Related]
9. Metformin and gut microbiota: their interactions and their impact on diabetes.
Vallianou NG; Stratigou T; Tsagarakis S
Hormones (Athens); 2019 Jun; 18(2):141-144. PubMed ID: 30719628
[TBL] [Abstract][Full Text] [Related]
10. High dose targeted delivery on cancer sites and the importance of short-chain fatty acids for metformin's action: Two crucial aspects of the wonder drug.
Maniar K; Singh V; Chakrabarti A; Bhattacharyya R; Banerjee D
Regul Toxicol Pharmacol; 2018 Aug; 97():15-16. PubMed ID: 29857113
[TBL] [Abstract][Full Text] [Related]
11. Structural Alteration of Gut Microbiota during the Amelioration of Human Type 2 Diabetes with Hyperlipidemia by Metformin and a Traditional Chinese Herbal Formula: a Multicenter, Randomized, Open Label Clinical Trial.
Tong X; Xu J; Lian F; Yu X; Zhao Y; Xu L; Zhang M; Zhao X; Shen J; Wu S; Pang X; Tian J; Zhang C; Zhou Q; Wang L; Pang B; Chen F; Peng Z; Wang J; Zhen Z; Fang C; Li M; Chen L; Zhao L
mBio; 2018 May; 9(3):. PubMed ID: 29789365
[TBL] [Abstract][Full Text] [Related]
12. Metformin Is Associated With Higher Relative Abundance of Mucin-Degrading Akkermansia muciniphila and Several Short-Chain Fatty Acid-Producing Microbiota in the Gut.
de la Cuesta-Zuluaga J; Mueller NT; Corrales-Agudelo V; Velásquez-Mejía EP; Carmona JA; Abad JM; Escobar JS
Diabetes Care; 2017 Jan; 40(1):54-62. PubMed ID: 27999002
[TBL] [Abstract][Full Text] [Related]
13. Metformin: old friend, new ways of action-implication of the gut microbiome?
Rodriguez J; Hiel S; Delzenne NM
Curr Opin Clin Nutr Metab Care; 2018 Jul; 21(4):294-301. PubMed ID: 29634493
[TBL] [Abstract][Full Text] [Related]
14. Pleiotropic effects of metformin: Shaping the microbiome to manage type 2 diabetes and postpone ageing.
Prattichizzo F; Giuliani A; Mensà E; Sabbatinelli J; De Nigris V; Rippo MR; La Sala L; Procopio AD; Olivieri F; Ceriello A
Ageing Res Rev; 2018 Dec; 48():87-98. PubMed ID: 30336272
[TBL] [Abstract][Full Text] [Related]
15. Prebiotic Mannan-Oligosaccharides Augment the Hypoglycemic Effects of Metformin in Correlation with Modulating Gut Microbiota.
Zheng J; Li H; Zhang X; Jiang M; Luo C; Lu Z; Xu Z; Shi J
J Agric Food Chem; 2018 Jun; 66(23):5821-5831. PubMed ID: 29701959
[TBL] [Abstract][Full Text] [Related]
16. Current understanding of metformin effect on the control of hyperglycemia in diabetes.
An H; He L
J Endocrinol; 2016 Mar; 228(3):R97-106. PubMed ID: 26743209
[TBL] [Abstract][Full Text] [Related]
17. Involvement of glucagon-like peptide-1 in the glucose-lowering effect of metformin.
Bahne E; Hansen M; Brønden A; Sonne DP; Vilsbøll T; Knop FK
Diabetes Obes Metab; 2016 Oct; 18(10):955-61. PubMed ID: 27265206
[TBL] [Abstract][Full Text] [Related]
18. The Gut Microbiome, Metformin, and Aging.
Induri SNR; Kansara P; Thomas SC; Xu F; Saxena D; Li X
Annu Rev Pharmacol Toxicol; 2022 Jan; 62():85-108. PubMed ID: 34449247
[TBL] [Abstract][Full Text] [Related]
19. Progressive Shifts in the Gut Microbiome Reflect Prediabetes and Diabetes Development in a Treatment-Naive Mexican Cohort.
Diener C; Reyes-Escogido ML; Jimenez-Ceja LM; Matus M; Gomez-Navarro CM; Chu ND; Zhong V; Tejero ME; Alm E; Resendis-Antonio O; Guardado-Mendoza R
Front Endocrinol (Lausanne); 2020; 11():602326. PubMed ID: 33488518
[TBL] [Abstract][Full Text] [Related]
20. Effects of Non-insulin Anti-hyperglycemic Agents on Gut Microbiota: A Systematic Review on Human and Animal Studies.
Cao TTB; Wu KC; Hsu JL; Chang CS; Chou C; Lin CY; Liao YM; Lin PC; Yang LY; Lin HW
Front Endocrinol (Lausanne); 2020; 11():573891. PubMed ID: 33071980
[No Abstract] [Full Text] [Related]
[Next] [New Search]
